Our E100 survey for H1, 2025 is coming together in extraordinary times. A major reorganization of the FDA is underway and Trump’s tariff war is raising alarms about imports and the economy. What have biotech execs been seeing? And what are they losing sleep over these days? We’ll cover the results of our survey in a wide-ranging panel conversation with a group of industry leaders. This is one conversation you won’t want to miss.
Register to watch on demand
No cost to register, subject to confirmation.
By registering for this event, you accept that you may receive direct communication from Endpoints News and/or the sponsor(s). View how we use your data here.
If you are experiencing problems with your registration, please contact our support team.